233 related articles for article (PubMed ID: 17544810)
21. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
[TBL] [Abstract][Full Text] [Related]
22. Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.
Gu C; Jenkins SA; Xue Q; Xu Y
J Immunol; 2012 May; 188(9):4421-31. PubMed ID: 22442442
[TBL] [Abstract][Full Text] [Related]
23. Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation.
Clarke EV; Weist BM; Walsh CM; Tenner AJ
J Leukoc Biol; 2015 Jan; 97(1):147-60. PubMed ID: 25381385
[TBL] [Abstract][Full Text] [Related]
24. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells.
Martin M; Leffler J; Blom AM
J Biol Chem; 2012 Sep; 287(40):33733-44. PubMed ID: 22879587
[TBL] [Abstract][Full Text] [Related]
25. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells.
Baruah P; Dumitriu IE; Peri G; Russo V; Mantovani A; Manfredi AA; Rovere-Querini P
J Leukoc Biol; 2006 Jul; 80(1):87-95. PubMed ID: 16617159
[TBL] [Abstract][Full Text] [Related]
26. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
Donat C; Thanei S; Trendelenburg M
Front Immunol; 2019; 10():2712. PubMed ID: 31824501
[TBL] [Abstract][Full Text] [Related]
27. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
Gullstrand B; Mårtensson U; Sturfelt G; Bengtsson AA; Truedsson L
Clin Exp Immunol; 2009 May; 156(2):303-11. PubMed ID: 19302245
[TBL] [Abstract][Full Text] [Related]
28. Immune modulation of human dendritic cells by complement.
Castellano G; Woltman AM; Schlagwein N; Xu W; Schena FP; Daha MR; van Kooten C
Eur J Immunol; 2007 Oct; 37(10):2803-11. PubMed ID: 17899552
[TBL] [Abstract][Full Text] [Related]
29. Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands.
Hester CG; Frank MM
Mol Immunol; 2019 Dec; 116():117-130. PubMed ID: 31634815
[TBL] [Abstract][Full Text] [Related]
30. SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen.
Prabagar MG; Do Y; Ryu S; Park JY; Choi HJ; Choi WS; Yun TJ; Moon J; Choi IS; Ko K; Ko K; Young Shin C; Cheong C; Kang YS
Cell Death Differ; 2013 Apr; 20(4):535-45. PubMed ID: 23238564
[TBL] [Abstract][Full Text] [Related]
31. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells.
Nauta AJ; Castellano G; Xu W; Woltman AM; Borrias MC; Daha MR; van Kooten C; Roos A
J Immunol; 2004 Sep; 173(5):3044-50. PubMed ID: 15322164
[TBL] [Abstract][Full Text] [Related]
32. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.
Roumenina LT; Sène D; Radanova M; Blouin J; Halbwachs-Mecarelli L; Dragon-Durey MA; Fridman WH; Fremeaux-Bacchi V
J Immunol; 2011 Oct; 187(8):4369-73. PubMed ID: 21930969
[TBL] [Abstract][Full Text] [Related]
33. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression.
Fraser DA; Bohlson SS; Jasinskiene N; Rawal N; Palmarini G; Ruiz S; Rochford R; Tenner AJ
J Leukoc Biol; 2006 Jul; 80(1):107-16. PubMed ID: 16617157
[TBL] [Abstract][Full Text] [Related]
34. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
Roumenina LT; Daugan MV; Noé R; Petitprez F; Vano YA; Sanchez-Salas R; Becht E; Meilleroux J; Clec'h BL; Giraldo NA; Merle NS; Sun CM; Verkarre V; Validire P; Selves J; Lacroix L; Delfour O; Vandenberghe I; Thuilliez C; Keddani S; Sakhi IB; Barret E; Ferré P; Corvaïa N; Passioukov A; Chetaille E; Botto M; de Reynies A; Oudard SM; Mejean A; Cathelineau X; Sautès-Fridman C; Fridman WH
Cancer Immunol Res; 2019 Jul; 7(7):1091-1105. PubMed ID: 31164356
[TBL] [Abstract][Full Text] [Related]
35. RAGE binds C1q and enhances C1q-mediated phagocytosis.
Ma W; Rai V; Hudson BI; Song F; Schmidt AM; Barile GR
Cell Immunol; 2012; 274(1-2):72-82. PubMed ID: 22386596
[TBL] [Abstract][Full Text] [Related]
36. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
37. Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.
Colonna L; Parry GC; Panicker S; Elkon KB
Clin Immunol; 2016 Feb; 163():84-90. PubMed ID: 26769276
[TBL] [Abstract][Full Text] [Related]
38. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
Clas F; Euteneuer B; Stemmer F; Loos M
Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
[TBL] [Abstract][Full Text] [Related]
39. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
40. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
